Editor’s Note Archive

The last month of 2013 had a significant number of fairly high profile, high value private equity (PE) deals focused on the…

This year has been about change; mostly on the regulatory front; both global and at the

At a recent industry seminar, there was general consensus that slipups by individual pharma companies were dragging down the…

The first fortnight of November saw the Drug Controller General of India (DCGI) crack down on Mumbai-based Sun Pharma and…

Squeezed between stringent regulations on the home front and sluggish global economic conditions, the Indian pharmaceutical market…

Two global pharma CEOs, two years apart, making essentially the same sounds

Ranbaxy's regulatory woes continued as the US FDA imposed an import alert on its third factory, the Mohali unit

The free-falling rupee is manna for some, and for others, a manic hunt for operating capital

India's 66th Independence Day was overshadowed by political bickering and economic turmoil as the rupee’s valuation to the dollar…

Now that the Ministry of Health and Family Welfare (MOHFW) has rolled back the ban on pioglitazone, it is time to mull over the…

If generic companies are constantly in the news for gross violations of manufacturing norms, their MNC counterparts share the…

Stringent regulations and ever increasing approval timelines are hampering the India pharma story, though recent recommendations…

Bilateral economics and border security issues top the agenda of any India-US strategic dialogue and the recent negotiations…

Dinesh Thakur's expose on Ranbaxy is not the first in the history of the pharmaceutical industry nor will it be the last

Ever since it was first celebrated in 1973, UNEP has used World Environment Day (June 5) to create awareness around…

Clinical research in India seems destined to be in the limelight for the wrong reasons

A fortnight after the Supreme Court of India delivered its judgment in the Novartis/ Glivec case

The world had barely digested and dissected the Supreme Court (SC) verdict on Novartis' Glivec when Glenmark fired another salvo…

In early March, BDR Pharmaceuticals International, a Mumbai-based company dealing in generic APIs and formulations, became the…

From the time of its discovery in 1882 by Robert Koch, to the first World TB Day a century later, the tubercle bacillus has…